TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC ...

At close: December 27 at 4:00:00 PM EST ...

We are pleased to invite you to attend our Special Meeting of Stockholders to be held virtually on February 4, 2025, at 9:30 a.m. EasteTime (the "Special Meeting"). At the Special Meeting, we will ...

BOSTON - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has revealed a study in collaboration with Michigan State University, which indicates that its leading therapeutic candidate,... ByInvesting.com • ...

Aaa Aaaaaa Aaaa 102.41 +31.96% ...

Analyst Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) and keeping the price target at $30.00. Discover the latest stocks ...

Percheron Therapeutics (AU:PER) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...

WUHAN, China, Jan. 2, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet ...

Gaza’s health ministry said that 88 people had been killed over the past day. Israeli and Hamas officials have been holding indirect cease-fire talks via mediators in Qatar. By Hiba Yazbek and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The non-profit Digital Therapeutics Alliance (DTA) – working with clinical trials specialist Curebase – has drawn up the document to help encourage the development of DTx products and get them ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...